Loading clinical trials...
Loading clinical trials...
The purpose of this study is to characterize the safety and tolerability of etelcalcetide in healthy young males.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
KAI Pharmaceuticals
Collaborators
NCT05382988 · Sodium Zirconium Cyclosilicate, Hyperkalemia, and more
NCT01290029 · Chronic Kidney Disease, Hyperparathyroidism, Secondary, and more
NCT01788046 · Hyperparathyroidism, Secondary
NCT01785875 · Hyperparathyroidism, Secondary
NCT01922843 · Hyperparathyroidism, Secondary, Kidney Failure, Chronic
Melbourne, Victoria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions